Onderneming WuXi Biologics (Cayman) Inc.
Aandelen
2269
KYG970081173
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,74 HKD | -1,24% | -3,78% | -56,96% |
Vakgebied
Aantal werknemers: 12 740
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Research Services on Fee-for-Service
83,6
%
| 9 684 | 78,1 % | 14 838 | 83,6 % | +53,22% |
Biologics Product
14,5
%
| - | - | 2 582 | 14,5 % | - |
Research Services on Full-Time-Equivalent
1,7
%
| 290 | 2,3 % | 309 | 1,7 % | +6,56% |
Project Management Organization Services
0,1
%
| 22 | 0,2 % | 26 | 0,1 % | +20,48% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
North America
55,6
%
| 6 302 | 50,8 % | 9 880 | 55,6 % | +56,78% |
China
24,4
%
| 3 026 | 24,4 % | 4 325 | 24,4 % | +42,92% |
Europe
16,7
%
| 2 743 | 22,1 % | 2 961 | 16,7 % | +7,93% |
Rest of the World
3,3
%
| 330 | 2,7 % | 590 | 3,3 % | +78,45% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 01-06-11 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 23-08-21 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Weichang Zhou
BRD | Director/Board Member | 59 | 01-12-12 |
Yue Huang
SEC | Corporate Secretary | - | 20-11-18 |
Ying Man Sham
SEC | Corporate Secretary | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 06-05-23 |
William Keller
BRD | Director/Board Member | 75 | 17-05-17 |
Ge Li
CHM | Chairman | 56 | 01-05-10 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 01-05-16 |
Yi Bing Wu
BRD | Director/Board Member | 55 | 01-05-16 |
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 01-06-11 |
Weichang Zhou
BRD | Director/Board Member | 59 | 01-12-12 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 09-06-20 |
Jue Chen
BRD | Director/Board Member | 54 | 16-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 259 278 169 | 3 655 307 975 ( 85,82 %) | 0 | 85,82 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
WuXi Biologics (Hong Kong) Ltd.
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,96% | 6,86 mld. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,75% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-9,12% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |
- Beurs
- Aandelen
- Koers 2269
- Onderneming WuXi Biologics (Cayman) Inc.